Keywords: altana, results, line, expectations, german, pharmaceuticals, group
Altana's results in line with expectations
Article | 06 February 2006
German pharmaceuticals group Altana AG has posted a 10% increase in 2005 full-year sales of 3.3 billion euros ($4.05 billion) and achieved operating sales ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Is failure to adopt business process management putting the pharma industry at risk?
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
